PMEDAP

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePMEDAP
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsNeoplasmsEpstein-Barr Virus InfectionsCytomegalovirus Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRega Institute for Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRega Institute for Medical Research +[2] 
Active IndicationsN/A
Inactive IndicationsNeoplasmsEpstein-Barr Virus InfectionsCytomegalovirus Infections +[5] 

Other Information

ATC CodeN/A
Related LinksN/A